Abbott Laboratories (Pakistan) (KAR:ABOT) Other Current Receivables : ₨2,471 Mil (As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Other Current Receivables?

Abbott Laboratories (Pakistan)'s Other Current Receivables for the quarter that ended in Mar. 2024 was ₨2,471 Mil.

Abbott Laboratories (Pakistan)'s quarterly Other Current Receivables declined from Sep. 2023 (₨2,951.76 Mil) to Dec. 2023 (₨888.35 Mil) but then increased from Dec. 2023 (₨888.35 Mil) to Mar. 2024 (₨2,471.20 Mil).

Abbott Laboratories (Pakistan)'s annual Other Current Receivables increased from Dec. 2021 (₨278.69 Mil) to Dec. 2022 (₨820.28 Mil) and increased from Dec. 2022 (₨820.28 Mil) to Dec. 2023 (₨888.35 Mil).

Abbott Laboratories (Pakistan) Other Current Receivables Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Other Current Receivables Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

258.68

229.29

278.69

820.28

888.35

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Receivables	Get a 7-Day Free Trial															2,409.44	2,758.01	2,951.76	888.35	2,471.20

Abbott Laboratories (Pakistan) Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Abbott Laboratories (Pakistan) Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines